{"id":"W2801721440","doi":"10.1007/s11899-018-0449-7","title":"Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Imatinib; Oncology; Disease; Tyrosine kinase; Imatinib mesylate; Tyrosine-kinase inhibitor; Internal medicine; Myeloid leukemia; Toxicity; Pharmacology; Intensive care medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009608223,0.000551753,0.001267887,0.00134728,0.0002002549,0.001164257,0.0009473969,0.0009885945,0.003994262],"category_scores_gemma":[0.001950304,0.0001851375,0.0007407138,0.001353112,0.0003988181,0.001375132,0.0005691577,0.001905482,0.0007662172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006414565,"about_ca_system_score_gemma":0.001366896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009878239,"about_ca_topic_score_gemma":0.002686879,"domain_scores_codex":[0.9997017,0.00008765691,0.00005751083,0.00004109329,0.00009003755,0.00002183822],"domain_scores_gemma":[0.9987999,0.0008610353,0.0001529911,0.00001448217,0.0001290218,0.00004247251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001126027,0.00005420166,0.000201006,0.02024562,0.0001778959,0.0001096099,0.00003899222,0.0004023977,0.00036011,0.003752015,0.02886107,0.9456845],"study_design_scores_gemma":[0.00009157696,0.0001380269,0.0011693,0.02569664,0.0006754977,0.001103696,0.0001167974,0.0002842879,0.0002461656,0.004628961,0.9658188,0.00003029649],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005208862,0.9988831,0.00006632043,0.0005316714,0.0001143949,0.000002491628,0.000011008,0.00000239559,0.0003365459],"genre_scores_gemma":[0.0006476267,0.9985134,0.0001634567,0.0003500698,0.0001838918,0.000003735983,0.00001805526,5.803556e-7,0.0001191729],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003994262,"threshold_uncertainty_score":0.01336211,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07998761122677826,"score_gpt":0.4216340902875697,"score_spread":0.3416464790607914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}